港股異動 | 中國有贊繼續上漲11% 月內累計飆漲高達235%
格隆匯11月18日丨中國有贊(8083.HK)延續強勢上漲行情,再度拉昇漲超11%,月內累計飆漲235%,現報0.235港元續刷階段新高,總市值43億港元。國盛證券日前報吿指,公司在降費方面,合理管控銷售和研發投入,通過人員優化,Q3費用端實現較大改善。展望未來,有贊商家結構望實現優化,推動其APRU、活躍度、續簽率提升。另外,安永報吿認為在綜合政策推動和社會需求增加的背景下,中國企業級SaaS公司已進入快速發展的黃金時代。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.